| GSE67980 | GSM1660157 | AB 5500xl Genetic Analyzer | Homo sapiens | Pr18.1.5 | lineage-confirmed PCa CTC CRPC progressed on enzalutamide (Group B) | donor: Pr18; donor type: CRPC; enzalutamide: progressed on enzalutamide (Group B) |
| GSE69405 | GSM1702705 | Illumina HiSeq 2500 | Homo sapiens | LC-PT-45-Re_SC47 | PDX, LC-PT-45-Re | cell type: PDX |
| GSE70580 | GSM1810660 | Illumina HiSeq 2000 | Homo sapiens | T75_P2_B12_ILC3 | Donor T75-tonsil innate lymphoid cell (ILC3) | tonsil donor: Donor T75; facs gating: ILC3; cell type: tonsil Innate lymphoid cells |
| GSE70580 | GSM1810916 | Illumina HiSeq 2000 | Homo sapiens | T86_P1_F8_ILC3 | Donor T86-tonsil innate lymphoid cell (ILC3) | tonsil donor: Donor T86; facs gating: ILC3; cell type: tonsil Innate lymphoid cells |
| GSE71318 | GSM1833321 | Illumina HiSeq 2500 | Homo sapiens | EarlyBlastocyst_#2 | human early blastocsyt | cell type: early blastocsyt |
| GSE72056 | GSM1850730 | Illumina NextSeq 500 | Homo sapiens | Cy72_CD45_C10_S706_comb | melanoma tumor | tumor-of-origin: Cy72 |
| GSE72056 | GSM1850986 | Illumina NextSeq 500 | Homo sapiens | Cy72_CD45_A08_S680_comb | melanoma tumor | tumor-of-origin: Cy72 |
| GSE72056 | GSM1851242 | Illumina NextSeq 500 | Homo sapiens | cy79-p1-CD45-pos-PD1-neg-AS-C1-R2-B12-S504-comb | B-cell | tumor-of-origin: cy79 |
| GSE72056 | GSM1851498 | Illumina NextSeq 500 | Homo sapiens | cy79-p1-CD45-neg-PDL1-pos-AS-C1-R1-D08-S44-comb | melanoma | tumor-of-origin: cy79 |
| GSE72056 | GSM1851754 | Illumina NextSeq 500 | Homo sapiens | cy79-p4-CD45-neg-PDL1-pos-E02-S434-comb | melanoma | tumor-of-origin: cy79 |
